Dexmedetomidine enhances recovery after gastrointestinal cancer surgery by protecting the endothelial glycocalyx: A randomized, double-blind, placebo-controlled study.

Receiver operating characteristic analysis identified syndecan-1 > 45 ng/mL at abdominal closure as a potential predictor of postoperative complications (area under the curve = 0.68, 95%CI: 0.59-0.76), and multivariable analysis showed a near-significant association (OR = 2.88, P = 0.057).

also in 1,038 other papers